MARKSANS PHARMA
Back to Income Statement
|
MARKSANS PHARMA Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹314 Cr | ₹266 Cr | ₹185 Cr | ₹236 Cr | ₹117 Cr |
What is the latest Consolidated Net Profit of MARKSANS PHARMA ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹314 Cr |
Mar2023 | ₹266 Cr |
Mar2022 | ₹185 Cr |
Mar2021 | ₹236 Cr |
Mar2020 | ₹117 Cr |
How is Consolidated Net Profit of MARKSANS PHARMA Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹314 Cr | 17.80 | |
Mar2023 | ₹266 Cr | 44.29 | |
Mar2022 | ₹185 Cr | -21.77 | |
Mar2021 | ₹236 Cr | 101.62 | |
Mar2020 | ₹117 Cr | - |
Compare Consolidated Net Profit of peers of MARKSANS PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MARKSANS PHARMA | ₹10,242.3 Cr | 1.6% | 9.3% | 38.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,648.0 Cr | -4.9% | 2.1% | 15.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,310.0 Cr | -2.2% | 9.3% | 50.5% | Stock Analytics | |
CIPLA | ₹119,410.0 Cr | -4.2% | 4.5% | 4.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹106,189.0 Cr | -4.4% | -4.5% | 17.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,496.4 Cr | -1.4% | 4.2% | -8.8% | Stock Analytics |
MARKSANS PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MARKSANS PHARMA | 1.6% |
9.3% |
38.2% |
SENSEX | -1.3% |
4.1% |
7.6% |
You may also like the below Video Courses